Form 4 for LXRX LEXICON PHARMACEUTICALS, INC.
Accepted 2024-02-29 00:00:00 ET · period of report 2024-02-28 · accession 0001127602-24-007629 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-02-29 | 2024-02-28 | LXRX | Alexander Kristen | VP, Fin, Accounting | F - Tax | $2.62 | -11.8K | 47.8K | -20% | -$30.9K |
| DM | 2024-02-29 | 2024-02-28 | LXRX | Alexander Kristen | VP, Fin, Accounting | M - OptEx | — | +29.2K | 59.6K | +96% | — |
| DM | 2024-02-29 | 2024-02-28 | LXRX | Alexander Kristen | VP, Fin, Accounting | M - OptEx | — | -29.2K | 0 | -100% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-28 | F | D | 11,793 | $2.62 | 47,800 | D | — | — | |
| 2 | Common | Common Stock | 2024-02-28 | M | A | 10,616 | — | 43,666 | D | — | — | (F1) Each restricted stock unit represents a contingent right to receive one share of common stock. |
| 3 | Common | Common Stock | 2024-02-28 | M | A | 2,700 | — | 33,050 | D | — | — | (F1) Each restricted stock unit represents a contingent right to receive one share of common stock. |
| 4 | Common | Common Stock | 2024-02-28 | M | A | 15,927 | — | 59,593 | D | — | — | (F1) Each restricted stock unit represents a contingent right to receive one share of common stock. |
| 5 | Derivative | Restricted Stock Units | 2024-02-28 | M | D | 15,927 | — | 31,853 | D | — · — to — | 15,927 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of common stock. (F3) Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. |
| 6 | Derivative | Restricted Stock Units | 2024-02-28 | M | D | 10,616 | — | 10,617 | D | — · — to — | 10,616 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of common stock. (F3) Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. |
| 7 | Derivative | Restricted Stock Units | 2024-02-28 | M | D | 2,700 | — | 0 | D | — · — to — | 2,700 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of common stock. (F3) Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. |